PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk shares drop 10% after poor weight loss trial result

Once-a-week injection achieved weight loss of 23%, which is lower than some existing treatments

23 Feb, 10:07 — 23 Feb, 10:07
PostShare

Sources

Showing 1 of 4 sources
FTVery High183d ago

Novo Nordisk shares drop 10% after poor weight loss trial result

Once-a-week injection achieved weight loss of 23%, which is lower than some existing treatments

Read full article →

Coverage Timeline

First report: FT · 23 Feb, 10:07Full coverage: 4 · 2hWindow: 2h
Left-leaningCenterRight-leaning
FT23 Feb, 10:07First to report

Novo Nordisk shares drop 10% after poor weight loss trial result

politiken23 Feb, 10:13

Novo Nordisk-aktie falder efter nye data om vægttabshåb

faz23 Feb, 10:37

Business-Ticker: Novo Nordisk-Aktie fällt um 11 Prozent – Rückschlag mit Abnehmmittel

1h later
naftemporiki23 Feb, 11:50Latest update

Novo Nordisk: Βουτιά 15% για τη μετοχή – Γιατί απογοήτευσε η κλινική δοκιμή του CagriSema

Related Stories

Average Age of Farmers Decreasing Amidst Mortgage Comparisons

1h ago

Treasury Secretary Bessent's Bond Strategy Faces Scrutiny and Criticism

11h ago

Analysts Assess NVIDIA's Valuation and Volatility Risks Following Weekly Stock Decline

13h ago

Richtech Robotics Announces Stock Repurchase Program, Shares Rise

14h ago